Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Retatrutide is an investigational peptide drug developed by Eli Lilly that acts as a triple agonist, simultaneously targeting three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Exercises like arm circles, leg swings, and spinal rotations prepare muscles for activity and reduce stiffness
Most peptides do not work immediately
IV infusions provide direct delivery in a monitored wellness setting
However, individual results may vary, and our team will help you choose the best option for your specific goals
[7] It should not be confused with currently licensed weight management medicines available in the UK
US$ 22.56
US$ 27.91
US$ 20.68
